These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20189798)

  • 1. The effects of radiofrequency ablation on the hepatic parenchyma: histological bases for tumor recurrences.
    Gravante G; Ong SL; Metcalfe MS; Bhardwaj N; Lloyd DM; Dennison AR
    Surg Oncol; 2011 Dec; 20(4):237-45. PubMed ID: 20189798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
    Xia JL; Ye SL; Zou JH; Ren ZG; Gan YH; Wang YH; Chen Y; Ge NL; Tang ZY; Yang BH
    Ai Zheng; 2004 Sep; 23(9):977-80. PubMed ID: 15363186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases.
    Elias D; Santoro R; Ouellet JF; Osmak L; de Baere T; Roche A
    Hepatogastroenterology; 2004; 51(60):1788-91. PubMed ID: 15532827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
    Hoffman AL; Wu SS; Obaid AK; French SW; Lois J; McMonigle M; Ramos HC; Sher LS; Lopez RR
    Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathomorphological changes after radiofrequency ablation in the liver.
    Kasper HU; Bangard C; Gossmann A; Dienes HP; Stippel DL
    Pathol Int; 2010 Mar; 60(3):149-55. PubMed ID: 20403040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrolytic ablation is as effective as radiofrequency ablation in the treatment of artificial liver metastases in a pig model.
    Hinz S; Egberts JH; Pauser U; Schafmayer C; Fändrich F; Tepel J
    J Surg Oncol; 2008 Aug; 98(2):135-8. PubMed ID: 18521836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation of colorectal liver metastases induces an inflammatory response in distant hepatic metastases but not in local accelerated outgrowth.
    Nijkamp MW; Borren A; Govaert KM; Hoogwater FJ; Molenaar IQ; van Diest PJ; Kranenburg O; Borel Rinkes IH
    J Surg Oncol; 2010 Jun; 101(7):551-6. PubMed ID: 20461760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic radiofrequency ablation of the liver in proximity to major vasculature: effect of the Pringle maneuver.
    Shen P; Fleming S; Westcott C; Challa V
    J Surg Oncol; 2003 May; 83(1):36-41. PubMed ID: 12722095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic radiofrequency ablation versus electrochemical treatment ex vivo.
    Czymek R; Loeffler S; Dinter D; Gebhard M; Schmidt A; Jungbluth T; Kleemann M; Bruch HP; Lubienski A
    J Surg Res; 2012 May; 174(1):106-13. PubMed ID: 21195429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiofrequency ablation of malignant liver tumors: use of a volumetric necrosis-tumor ratio for local control].
    Kühl H; Stattaus J; Kühl B; Boes T; Antoch G; Frilling A; Forsting M
    Rofo; 2006 Dec; 178(12):1243-9. PubMed ID: 17136648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.
    Chow DH; Sinn LH; Ng KK; Lam CM; Yuen J; Fan ST; Poon RT
    J Surg Oncol; 2006 Dec; 94(7):565-71. PubMed ID: 17048238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses.
    Zerbini A; Pilli M; Penna A; Pelosi G; Schianchi C; Molinari A; Schivazappa S; Zibera C; Fagnoni FF; Ferrari C; Missale G
    Cancer Res; 2006 Jan; 66(2):1139-46. PubMed ID: 16424051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation of hepatocellular carcinoma.
    Curley SA; Izzo F
    Minerva Chir; 2002 Apr; 57(2):165-76. PubMed ID: 11941292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery.
    Park IJ; Kim HC; Yu CS; Kim PN; Won HJ; Kim JC
    Ann Surg Oncol; 2008 Jan; 15(1):227-32. PubMed ID: 17882491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of radiofrequency ablation for the treatment of metastatic liver cancers.
    Nouso K; Kobayashi Y; Nakamura S; Uematsu S; Shiraga K; Iwadou S; Araki Y; Taniguchi H; Tanaka H; Toshikuni N; Kaneyoshi T; Ikeda H; Fujioka S; Osawa T; Iwasaki Y; Shiraha H; Yamamoto K
    Hepatogastroenterology; 2010; 57(97):117-20. PubMed ID: 20422885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation for malignant liver tumor.
    Ng KK; Poon RT
    Surg Oncol; 2005 Jul; 14(1):41-52. PubMed ID: 15777889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic radiofrequency ablation of metastatic ovarian granulosa cell tumors.
    Jacobs IA; Chang CK; Salti G
    Am Surg; 2003 May; 69(5):416-8. PubMed ID: 12769214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.